Friday 27 September 2019

Laboratory Information Systems Market Analysis, Development Trend and Investment Feasibility | Forecast To 2027

The global Laboratory Information Systems Market size is expected to grow at a CAGR of 7.3% between 2016 and 2025, driven by growth from both developed and emerging markets. Laboratory information system (LIS) is a comprehensive information system developed and configured to process, store and manage information pertaining to industrial and medical-related laboratories which include clinical and analytical laboratories. LIS plays an important role in streamlining the process and generating high quality data to support effective clinical decisions. The LIS provides information that helps hospitals in the diagnosis, prevention, management and treatment of diseases, and acts an indicator for public health. The LIS has now emerged as a necessity for both small and large diagnostic and drug companies’ laboratories. The ability of both clinical and analytical laboratories to better manage data and incorporate collaborative technological tools into their day-to-day operations has become critical to remain competitive.

LIS, used in both large- and small-scale companies, provide a platform to automatically obtain, store and archive information, track samples, and generate reports efficiently. The LIS products vary widely in terms of cost, sophistication, and industrial focus. As industrial and medical laboratories are diverse with different requirements, hence, there is no standard information system designed for laboratories. Therefore, a LIS is customized, developed, and configured according to the requirements of a laboratory.


There are various different applications of LIS including drug delivery and clinical diagnostics. LIS in clinical diagnostics includes anatomic pathology systems; microbiology, genetic and molecular diagnostics support systems; blood bank systems; and billing or accounts receivable or revenue cycle management (RCM) systems.
Major components of LIS are hardware, software and services. Hardware mainly includes servers as well as data input, output and storage devices. Software includes the interface of integrated LIS which helps managing and analysing data in an efficient manner. Whereas, the key delivery modes used for LIS, include web based, on premise, mobile solutions and cloud-based technology.

Global Laboratory Information Systems Market – Regional Analysis
Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa. The North America dominated the global Laboratory Information Systems market. The adoption of cloud computing is expected to rise in the U.S. healthcare sector due to continuous pressure to lower cost for customized healthcare services. According to clauses of the HIPAA, the healthcare industry in the U.S. has to adopt new systems that support electronic medical records (EMR) and share data in an efficient and secure manner with other healthcare providers and government agencies. This will lead to higher adoption of cloud-based LIS, which allow laboratories to share real-time information with hospitals and patients. In terms of LIS usage, North American and Western European markets are witnessing penetration, due to early adoption of healthcare technologies.


The European LIS market is expected to grow moderately, driven by higher incidence rate of diseases and increasing patient awareness about new technologies. In addition, various government initiatives also helped in promoting the usage of LIS. Increasing demand for better healthcare facilities and rising need for integrated healthcare systems in the two regions are some of the key driving factors for these markets.

The LIS market is expected to grow in Asia-Pacific (APAC) due to increase in the incidences of diseases. Asia and Latin America are among the fastest growing markets for LIS; rising investments from healthcare IT players and government initiatives are some of the key driving factors for LIS in these regions. Many international LIS firms have started investing in developing regions of the world, such as Asia and Latin America, in order to increase their presence in high potential markets.

Brows More Healthcare Related Research Reports:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Ischemic Stroke Market Growth, Size, Dynamics | Forecast To 2023

Global Ischemic Stroke Market size is expected to grow at a CAGR of 8.3% over the forecast period between 2017 and 2023 Predicted by Market Research Future (MRFR). Ischemic stroke market to witness significant growth due to increasing ageing population, evolving lifestyle of individuals, occurrence of diabetes and high tobacco usage. Additionally, the advancements in surgical procedures and increasing demand for minimally invasive procedures key factors accelerating the growth of the global Ischemic stroke market.

Market Segmentation
The Global Ischemic Stroke Market segmentation is based on key dynamics like drug class, diagnosis, end-users, and surgery.

By drug class, the market segments into
  • anticoagulant
  • tissue plasminogen activator
  • antihypertensive
  • antiplatelet
By diagnosis, the market includes
  • carotid ultrasound Computed Tomography (CT)
  • echocardiography
  • cerebral angiography
  • Magnetic resonance imaging (MRI)
  • electrocardiography

By end-user, the market comprises of
  • medical institutes
  • research organizations
  • hospitals & clinics
By surgery, the market divides into
  • endovascular mechanical thrombectomy
  • carotid endarterectomy
  • angioplasty
Competitive Landscape
The Global Ischemic Stroke Market includes numerous prominent players like
  • Stryker Corporation (U.S.)
  • Johnson & Johnson (U.S.)
  • Abbott Laboratories (U.S.)
  • Genentech, Inc. (U.S.)
  • Merck & Co., Inc. (U.S.) 
  • Sanofi (France)
  • Bayer AG (Germany)
  • Koninklijke Philips N.V. (Netherland)
  • Boston Scientific Corporation (U.S.)
  • Medtronic plc (U.S.)
  • Siemens Healthcare (U.S.)
  • Pfizer Inc. (U.S.)
  • GE Healthcare (U.S.)
  • Covidien PLC (Ireland)
  • GE Healthcare (U.S.) 
  • Philips Healthcare (U.S.)
  • Hitachi, Ltd (Japan)
  • Boehringer Ingelheim (Germany)
  • Penumbra, Inc. (U.S.)
  • Cordis Corporation (U.S.) 
  • Daiichi Sankyo (U.S.)
  • Biogen (U.S.)

Regional Analysis
The Global Ischemic Stroke Market is geographically segmented into the following regions: Asia Pacific
  • America
  • Europe
  • Middle East
  • Africa
Brows More Healthcare Related Reports:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Electrotherapy Market Analysis, Growth Impact and Demand By Regions | Forecast To 2023

The Electrotherapy Market size is expected to reach USD 1119.1 million with a 4.2% CAGR by the end of the forecast period says Market Research Future (MRFR). Electrotherapy Market is projected to grow rapidly owing to rising in the number of cases related to soft tissue injuries and muscles impairments which increasing the demand for electrotherapy devices. The electrotherapy market is expected to witness significant growth due to the increased inclination of customers towards drug-free methods of treatment. Furthermore, the awareness of the benefits of electrotherapy is anticipated to provide more avenues for growth in the upcoming forecast period.
The rise in the acceptance of physiotherapy for treating various ailments has also bolstered the demand for electrotherapy globally. Market reports linked to the medical device industry have been made available by Market Research Future which creates reports on other industry verticals that outlines the current market scenarios.


Competitive Analysis
The noteworthy competitors in the electrotherapy market are
  • Eme srl (Italy)
  • BTL (Czech Republic)
  • EMS Physio Ltd. (UK)
  • Medtronic (Republic of Ireland)
  • Enraf-Nonius B.V.(Netherlands)
  • Pure Care (US)
  • gbo Medizintechnik AG (Germany)
  • Phoenix Healthcare (UK)
  • Omron Healthcare Inc. (US)
  • Walgreen Co. (US)
  • STYMCO Technologies
  • LLC (US) and others
Segmental Analysis

The electrotherapy market has been segmented on the basis of
  • Type
  • Devices
  • Application
  • Region
On the basis of type, the market is segmented into
  • Interferential
  • Extracorporeal Shock Wave Therapy
  • Magnetic Field Therapy (Pulsed Electro-Magnetic Field Energy, Constant Energy Magnets) Transcutaneous Electrical Nerve Stimulation (TENS) Therapy (Intense TENS, Conventional TENS, Acupuncture-like TENS (AL-TENS))
  • Ultrasound Therapy
The segmentation on the basis of devices comprises of
  • Electronic Muscle Stimulator (EMS)
  • High Voltage Pulsed Galvanic Stimulator (HVPGS)
  • Transcutaneous Electrical Neural Stimulator (TENS)
  • Interferential Stimulator (IF)
  • Microcurrent Stimulator (MC)

The segmentation of the electrotherapy market on application basis comprises of
  • orthopedics
  • cardiology
  • urology
  • pain management (chronic fatigue, chronic pain, migraine headaches, diabetic nerve pain, wound healing, stimulating bone growth)
  • Chronic and Acute Edema among others.
Detailed Regional Analysis 

The regions covered in the market are
  • Europe
  • North America,
  • Asia Pacific
  • Africa and the Middle East.
Brows More Healthcare Related Research Reports

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Friday 20 September 2019

Insulin Pump Market Size, Share, Future Trends, Top Key Players and Business Overview Till 2026

Insulin Pump Market Analysis By Types (Disposable Insulin Pump and Traditional Insulin Pump), End Users (Home Care, Laboratories, Hospital & Clinics), Regional Outlook, Size, Share, Upcoming Trends, and Leading Companies, Forecast To 2023

Insulin Pump Market size is expected to reach USD 8.52 billion with growing CAGR of 8.4% by 2023. An Insulin Pump is a small electronic device which provides the insulin to body requires whole day and nights. There two types of insulin pumps tethered pump and a patch pump. it regulates blood sugar level and beneficial compared to multiple daily injections, highly convenient to use, offers tremendous flexibility, and gives a detailed record of insulin dose, blood sugar value and carb.

There are several factors responsible for propelling the growth of the insulin pump market. These factors include
  • Rising incidence of diabetes
  • Benefits over injections such as flexibility
  • Glucose control
  • Growing awareness about insulin pumps among the population
  • Rise in geriatric population
  • Preference for methods that are non-invasive and technological development.
On the contrary, high costs of such devices, skin infection and lack of skilled professionals are factors that may hinder the insulin pump market growth.


Insulin Pump Market Top Companies
Top Key players profiled in the Insulin Pump Market include
  • Dickinson
  • Company
  • Becton
  • Insulet Corporation,
  • Hoffman-La Roche AG
  • Abbott Laboratories
  • Sanofi
  • Medtronics
  • Braun Melsungen AG
Insulin Pump Market Segmentation
Insulin Pump Market Segmented based on
  • type
  • end use
Based on type, it is segmented into
  • disposable
  • traditional insulin pumps
Based on end use, the insulin pump market is segmented into
  • laboratories
  • home care
  • hospitals
Regional Analysis
By region, the Insulin Pump Market Segmented to
  • North America,
  • Europe,
  • Asia Pacific
  • Rest of the World.
Drivers
  • Increasing Prevalence Of Diabetes
  • Rise In Global Obesity Population
  • Technological Advancement In Drug Delivery Devices
  • Growing Global Awareness Of Diabetic Care
  • Restraints
  • Risks And Disadvantages Associated With Insulin Pumps
  • High Costs Of Insulin And Insulin Pumps
Make an Enquiry Before Buying this Report @ https://www.marketresearchfuture.com/enquiry/1637

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +16468459312

3D Bioprinting Market 2019 Trends, Size Analysis, Share, Leading Companies, Future Insights and Top Manufacturers, Forecast To 2026

Market Analysis:
Global 3D Bioprinting Market size is anticipated to reach USD 1,923.02 Million with growing at a CAGR of 24.5% over the forecast period 2018 to 2023. 3D bioprinting leverages 3D printing technology for the formation of biomedical components using biomaterials to imitate natural tissues and organs. Rising Cases of Organ Failures Expected to Motivate Growth Trajectory of 3D Bioprinting Market
The cost-effective nature of the technology is expected to drive the market demand as well. Opportunities related to the manufacturing of pills for the pharmaceutical sector and for producing prosthetics and implants is anticipated to augment the market too. The rising investment for R&D activities is expected to broaden the potential of the technology and subsequently the market growth.
It is reported that the growing demand for organ transplantation is expected to push the growth of the 3D Bioprinting Market. Also, rising occurrences of organ failure owing to accidents, diseases, and old age have created a massive gap for the functioning of organs. The emergence of 3D bioprinting can fill-in the gap by producing them on a massive scale.
3D Bioprinting Market Competitive Dashboard:
Top companies operating in the global 3D bioprinting market are
  • Cellink AB (Sweden)
  • Stratasys Ltd. (U.S.)
  • Organovo Holdings Inc. (U.S.)
  • FUJIFILM Wako Automation Corporation (U.S.)
  • Regenovo Biotechnology Co. Ltd. (China)
  • Nano3D Biosciences Inc. (U.S.)
  • EnvisionTEC GmbH (Germany)
  • Allevi (U.S.)
  • REGENHU Ltd. (Switzerland)
  • Aspect Biosystems Ltd. (Canada)
  • Cyfuse Biomedical K.K. (Japan)
  • Poietis (France)
3D Bioprinting Market Segmentation:
Based on technology, the segments of the global 3D bioprinting market are
  • micro extrusion bioprinting
  • magnetic 3D bioprinting
  • inkjet 3D bioprinting
  • laser-assisted bioprinting
The segmental analysis of the 3D bioprinting market, on the basis of
  • material
  • covers extracellular matrices
  • living cells
  • hydrogels
The major applications-wise segments studied in the assessment of 3D bioprinting market are research and clinical applications.
The end-users identified in this MRFR report are research organizations & academic institutes, and pharmaceutical & biotechnology companies.
Regional Analysis:
The regional assessment of the 3D bioprinting market covers a detailed analysis of the four regional segments along with an exhaustive country-level analysis. The regions included in the analysis are - Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
America
  • North America
  • US
  • Canada
  • South America
Europe
  • Western Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest Of Western Europe
  • Eastern Europe
Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Republic Of Korea
  • Rest Of Asia Pacific
Middle East & Africa
  • United Arab Emirates
  • Saudi Arabia
  • Oman
  • Kuwait
  • Qatar
  • Rest Of Middle East & Africa
3D Bioprinting Market Table of Content:
  • Report Prologue
  • Executive Summary
  • Market Introduction
  • Research Methodology
  • Market Dynamics
  • Market Factor Analysis
  • Global 3D Bioprinting Market, by Technology
  • Global 3D Bioprinting Market, by Material
  • Global 3D Bioprinting Market, by Application
  • Global 3D Bioprinting Market, by End User
  • Global 3D Bioprinting Market, by Region
  • Competitive Landscape
  • Company Profiles
  • Appendix
  • List of Tables
  • List of Figures
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +16468459312
Email: sales@marketresearchfuture.com

Contrast Media Market 2019 Size Analysis, Share Value, Future Trends, Regional Outlook and Leading Companies Till 2026

Overview:
Market Research Future (MRFR) predicts the Global Contrast Media Market to register a 6.3% CAGR during the forecast period of 2017 – 2023. Contrast Media is a substance that enhances the visibility of internal organs during radiography.  Medical imaging plays a crucial role in diagnosis of diseases, like GI disorders, cancer diagnosis, and cardiovascular complications.

The World Health Organization (WHO) reported that by 2020, three-quarters of global deaths will be caused due to chronic diseases of which 71-75% of deaths will be due to cardiac related problems. Early detection of such ailments can help provide patients with better treatment.  The increase in prevalence of chronic disease and cancer patients necessitates better diagnostic techniques provoking elevated use of contrast media. This is expected to bolster the contrast media market in the forecast period.


Key players:

Prominent companies in the contrast media market are
  • AMAG Pharmaceuticals (US)
  • Bracco Diagnostic Inc. (Italy)
  • Lantheus Medical Imaging (U.S.)
  • Covidien (Ireland)
  • Mallinckrodt Pharmaceuticals (UK)
  • Targeson (US)
  • nanoPET Pharma GmbH (Germany)
  • NanoScan Imaging (US)
  • Medrad Inc. (US)
  • Guerbet Group (France)
  • Subhra Pharma Private Limited (India)
  • GE Healthcare (US)
  • CMC Contrast AB (Sweden)
  • Daiichi (Japan)
  • Bayer Healthcare Pharmaceuticals (Germany)
Contrast Media Market Segmental Analysis

The contrast media market study is segmented into
  • Type
  • Procedure
  • Application
  • Route of application
Based on the type, the market is segmented into
  • Intravenous contrast materials
  • Iodine-based contrast media agents
  • Others
Based on the application, the market is segmented into
  • nephrological disorders
  • oncology
  • cardiovascular disorders
  • others
Based on the route of administration, the market is segmented into
  • Injectable
  • Rectal
  • Oral
Contrast Media Market Regional Insights

MRFR’s regional analysis of the Contrast Media Market gives a holistic approach towards the demographic progress of the market in the forecast years. Based on the region, the contrast media market is segmented into Asia Pacific, North America, Europe, and the Rest-of-the-World (RoW).

North America is expected to dominate the market, holding a significant market share owing to its strong technological infrastructure. Increase in medical tourism, rise in the number of cancer patients and patients suffering from chronic disorders, and market players likely to deliver cost-competitive contrast media products are factors which are predicted to fuel the regional market growth. 

Robust economic improvement, existence of influential market players, and technological advancements in the European region can augment the regional market proliferation.

The contrast media market in the Asia Pacific region, led by the rapidly proliferating healthcare sector and developing economy, has emerged as a promising market, globally. Increasing markets in countries, such as Japan, China, and India, are pushing up the growth in the regional market. Moreover, the APAC Contrast Media Market is driven by the rising population and the spreading awareness towards the functionalities of contrast media.

The rapidly growing healthcare industry and emerging economies like India, Japan, and China in the Asia Pacific region, a huge population, and increase in awareness towards benefits of contrast media are market dynamics expected to drive the regional market growth.


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Tuesday 17 September 2019

Medical Ventilator Market SWOT Analysis | Application and Demand | Forecast To 2023

Medical Ventilator Market Overview by Share, Size, SWOT Analysis, Segmentation, Emerging Trends, Future Outlook, Applications, Insights, Profile, key Players, Future Outlook, PESTEL analysis with Regional Insights of North America, Asia-Pacific, Europe, and the Middle East & Africa, Forecast To 2023.

The extensively conducted Medical Ventilator Market study by Market Research Future (MRFR) reveals that the demand for ventilators is increasing due to the amalgamation of various factors. A medical ventilator is an artificial respiratory assistance machine that is designed to provide ventilation to patients who struggle with breathing. Assisting individuals with their breathing is a highly delicate task, wherein the reliability and safety of the equipment is of utmost importance. Ventilators are primarily used in intensive care medicine, emergency medicine, home care, and in anesthesiology.

It provides mechanical ventilation by passing breathable air into and out of the lungs. Some of the major reasons behind needing a medical ventilator are Cystic Fibrosis, injury to the spinal cord, drug overdose, pneumonia or any other type of respiratory disease, stroke, Chronic Obstructive Pulmonary Disease (COPD), blood clot, during surgery that requires general anesthesia, lung injury, and while being in intensive care. Ventilators are either invasive or non-invasive and mechanical. The factors include the rising percentage of critically ill patients, prevalence of lifestyle-based disorders like respiratory issues and heart attacks, high occurrences of chronic illness among children, and the need for ventilators in emergency care. The expected market growth of Medical Ventilators is projected to be 7.9% during the forecast period.

However, amidst the market growth and proliferating demand, there lies a risk associated with the use of ventilation. Patients can be diagnosed with pneumonia if they are ventilated for a long period of time. Not to mention, pneumonia is one of the most common hospital-acquired infections.

Competitive Analysis
Some of the key players in the medical ventilators market are Koninklijke Philips N.V. (the Netherlands), Medtronic (Ireland), Dickinson and Company (U.S.), Hamilton Medical (Switzerland), Allied Healthcare Products Inc. (U.S.), ResMed (U.S.), Teleflex Incorporated (U.S.), General Electric Company (U.S.), and Becton (U.S.)

Oct 2018, an Asahi Kasei Group company named ZOLL Medical Corporation, which manufactures medical devices and relevant software solutions, announced the introduction of Z Vent transport ventilator for usage in pre- and intra-hospital. The Z Vent possesses a simple Touch, Turn, and Confirm interface that makes ensures quick setting changes. The move is aimed at removing the complexity that is associated with various portable ventilators.
Nov 2018, world-renowned technology company announced that its V60 Plus Ventilator has received the CE Mark of approval. The Ventilator is designed to ensure optimal efficiency and enhance clinician workflow.

Market Segmentation
The market segmentation of the medical ventilators is segmented in terms of type and application.
By type, the market includes invasive, non-invasive, and mechanical ventilators. The non-invasive ones are further sub-segmented into pressure-cycled, volume-cycled, time-cycled, and flow-cycled ventilators. Mechanical ventilators are narrowed down into negative-pressure ventilators and positive pressure ventilators.
By applications, the market includes emergency care, critical care, neonatal care, and others.


Regional Analysis
The regional analysis of Medical Ventilators provides us with a better overview of the market. The market comprises of four major regions: Asia-Pacific, the Middle East & Africa, Americas, and Europe.
Americas is the largest market player of medical ventilators worldwide with over 60% of the global share due to a number of factors. The increasing incidences of lifestyle-based diseases leading to disorders like asthma, bronchitis, chronic obstructive pulmonary diseases, and other disorders are driving the market growth in this region. Additionally, an increasing percentage of patients in critical state, increasing surgical procedures, rising smoking addiction, and the presence of a wide array of medical device manufacturers in the US are all key factors boosting the market growth.

Europe comes in second in terms of market growth and much of it can be attributed to the growing population of chronic respiratory diseases, demand for mechanical ventilators, and other factors.
Asia Pacific is slated to be the fastest-growing regional market. The wide-spread prevalence of respiratory and chronic heart diseases, threatening environmental pollution, and the presence of a large patient pool are all projected to contribute to the growth of the market herein. Lastly, the Middle East & Africa is expected to show slow and steady progress during the assessment period.

Brows More Healthcare Related Research Reports:
About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312

Medical Billing Market Dynamics | Trends and Insights | Forecast To 2023

Medical Billing Market Overview by Share, Size, SWOT Analysis, Segmentation, Emerging Trends, Future Outlook, Applications, Insights, Profile, key Players, Future Outlook, PESTEL analysis with Regional Insights of North America, Asia-Pacific, Europe, and the Middle East & Africa, Forecast To 2023
Market Research Future (MRFR) in its recently published study report mentions that the global Medical Billing Market will rise to witness a spectacular growth by 2023, growing at a CAGR of 6.5% during the review period 2017-2023. Medical billing, a payment practice involved in receiving payments, submitting bills and payment follow-up is witnessing a wide uptake across the healthcare sector, evolving rapidly with the technological advancements. Over the past few years, while, the healthcare sector is booming and perceiving increasing healthcare expenditures all around the world, some concerns pertaining to the billing and reimbursement are growing too.
Those raising concerns include increasing cases of fraud billings, disputes, and prolonged reimbursement processes.  Simultaneously, there is a huge demand to control those concerns to enhance patients’ experience and thus their quality of life by offering them some peace over these disruptive environments. The cumulative effect of these two factors is supporting the growth of the medical billing market. Furthermore, the advancement in Information technology is escalating the market on the ascending levels on the global platform.
Considering the phenomenal growth prospect demonstrated by the market,
The market is expected to perceive a steady growth over the next five years, as the growing geriatric population creates demand via Medicare. Furthermore, the number of insured people will rise in line with healthcare reform, as people with pre-existing conditions can receive insurance. The growing senior population will keep driving demand for the medical services over the next five years, helping the revenue to blossom.
Increasing implementation of several healthcare IT platforms poses a significant impact on the acceptance and growth of this market. The factors such as efforts to contain and decrease in-house processing costs, the requirement of error minimization, meeting federal mandates to implement digital record-keeping by healthcare providers, and changing healthcare regulations are projected as market growth propelling factors. Implementation of RCM by medical providers has improved their cash flow, reduced claim denials, and helped them gain an analytical approach to allocate resources and ensure effective revenue management.
Additional factors that influence the growth of medical billing market are the increased expenditure in healthcare, increasing use of the Internet, increased need for risk and compliance management, increasing digitalization in the healthcare industry and many others.  However, the factors such as high costs of technology, the reluctance of providers to provide patient records to third-party sources may hamper the growth of the market.
Medical billing sometimes also referred to as revenue cycle management (RCM), includes the most complex and crucial components of the healthcare IT business. Due to the lack of expertise in tackling new payment models and revenue management tools; current systems in practice for managing revenue are becoming outdated with the time. Providers are confronting with the challenges while managing the flooding claims and reimbursements, resulting in huge losses.
The emergence of updated technological solutions, increasing government requirements, and bad debt &uncollectible accounts have induced a new trend leading to the increased preference for medical billing outsourcing by several healthcare providers.
Global Medical Billing Market – Segmentations
MRFR analysis is segmented into four key dynamics for the enhanced understanding;
By Types: Comprises Professional Billing, and Institutional Billing, others.
By Applications: Database Management, Financial, Infrastructure, and Operational among others.
By Processes: Electronic Billing, Payment and Medical Billing Services among others.
By Regions:  North America, Europe, APAC and Rest-of-the-World.
Global Medical Billing Market – Regional Analysis
Globally, North America accounts for the leading market for Medical Billing. Countries like U.S. and Canada play a vital role in the growth of this market. Increasing demand to curtail the medical bills that are skyrocketing currently. Higher per capita healthcare expenditures and rising R&D funding to develop new technologies are some of the major factors supporting the growth of the market in the region. Furthermore, the extensive growth of the information technology in the healthcare industry is also one of the factors driving the growth of the market.
Europe is expected to be the second-largest market and is expected to show extensive growth throughout the forecast period. Factors such as the financial support from the government for research and development activities and growing emphasis on transparent billing methods in the region drive the market growth.
Furthermore, Asia Pacific Medical Billing market is emerging as one of the lucrative markets. Increasing occurrences of chronic diseases, coupled with the increasing incidences of billing frauds in the region are the major driving forces for the growth of the market.
Global Medical Billing Market – Competitive Analysis
Key Players are focusing on streamlining their offerings and pinpoint areas that would lead to cost improvement. Rising demand for medical claims processing services has attracted new entrants to the industry. A Large number of healthcare providers are shiftuing to end-to-end outsourcing firms to manage their billing processes effectively.
Recognizing the financial benefits offered by the outsourcing firms, the providers are relying on billing service providers to handle high-volume transactions and maximize their operating margins. As these practices are being standardized; healthcare providers are realizing their benefits.
Key Players:
Identified and profiled in MRFR analysis; the key players that are involved in global medical billing market are TCS (India), Accenture (US), AGS Health (India), GeBBS Healthcare (US), Cognizant Technology Solutions (US), Genpact (US), INFINIT Healthcare, HCL Technologies (India), and Medusind (India) among others.
Industry/Innovation/Related News:
DrChrono (US), a leading provider of the best EHR, practice management, medical billing and RCM experiences, announced its partnership with Stitch Health (US), a platform for care coordination to provide Y Combinator portfolio.
AdvancedMD (US), a leading global provider of Rhythm, an end-to-end cloud platform that automates all aspects of clinical and business workflow for medical billing services and independent physician practices, announced the acquisition of Marietta, (US), a leading provider for Nuesoft Technologies (NueMD). The transaction is expected to add to AdvancedMD’s leading market position, extending the feature and functionality for both companies to be able to provide practices across the broader ambulatory market.
Cedar Inc. (US), a patient billing startup, personalizing the medical billing experience announced receiving funding of 36 Mn. USD from a group of venture capitalists.
Brows More Healthcare Related Research Reports:
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312

Blood Glucose Test Strip Market Share, Size and Future Outlook | Forecast To 2020

Blood Glucose Test Strip Market Overview by Share, Size, SWOT Analysis, Segmentation, Emerging Trends, Future Outlook, Applications, Insights, Profile, key Players, Future Outlook, PESTEL analysis with Regional Insights of North America, Asia-Pacific, Europe, and the Middle East & Africa, Forecast To 2020

The Blood Glucose Test Strip Market is presumed to garner USD 18.5 billion during the forecast period (2015-2020). The market is presumed to register 6.2 % CAGR owing to the increasing diabetic population, asserts Market Research Future (MRFR). Blood glucose test strip can be referred to as a small non-reusable plastic strip. It is a crucial component of blood glucose meters that helps to monitor and control diabetes.

Drivers and Constraints Impacting the Market
Blood glucose test strips are self-testing strips which let pre-diabetic and diabetic people track their blood glucose level on a regular basis without visiting a diagnostic laboratory or a clinic. With the growing diabetic population, the global market for blood glucose test strip is considered to foster during the assessment period. For instance, as per the International Diabetic Federation, around 415 million people had diabetes in 2015. The number is estimated to reach 642 million by the end of 2040. Moreover, technological advancements such as accuracy of the tests along with awareness among the people regarding diabetes are stimulating the market growth.


On the flip side, product recall owing to the inefficiency of devices such as intense competition resulting in pricing pressure and false glucose reading are some of the major factors considered to impede the global blood glucose test strip market in the coming years.

Global Blood Glucose Test Strip Market: Segmental Analysis
The blood glucose test strip market has been segmented on the basis of technology, distribution channel, and region.
By mode of technology, the global blood glucose test strip market has been segmented into optical, thin film electrochemical, and thick film electrochemical.

By mode of distribution channel, the global blood glucose test strip market has been segmented into retail pharmacy and hospital pharmacy. Among these, the hospital pharmacy is likely to dominate the global market and is anticipated to maintain its dominance over the assessment period. The growth is attributed to the increasing preference for self-care testing among the patients to monitor diabetes.

Regional Insights
Geographically, the global blood glucose test strip market span across regions namely, North America, Europe, Asia Pacific, and the Middle East and Africa.

Among all the regions, North America is presumed to lead the global blood glucose test strip market with $ 7.89 billion revenue. The growth is attributed to the extensive use of information technology coupled with high expenditure on healthcare. Moreover, the presence of major medical device manufacturers and high adoption of latest technologies are considered to stimulate the market during the review period.


Europe is estimated to hold the second position in the global market and is likely to maintain its dominance during the review period. High healthcare expenditure led by France and Germany is anticipated to drive the global market.
The Asia Pacific region is presumed to expand at a rapid pace owing to the presence of major regions such as India and China which are expected to lead the market due to unmet needs. This region is presumed to expand at 12.9 % CAGR owing to the growing number of diabetic populations.

Industry Updates
Ascensia Diabetes Care has recently announced the expansion of its strategic alliance with the Insulet Corporation which is a leader in tubeless insulin pump technology. The expansion follows the worldwide non-exclusive development agreement that Ascensia had announced, to connect its CONTOUR NEXT ONE blood glucose monitoring system with Insulet's next-generation Omnipod System.

Competitive Dashboard
The major players operating the global market are Apex Biotechnology Corp, Shanghai MicroSense, ALL Medicus, Beijing Yicheng Electronics, Elektronika, Nipro Diagnostics, Bayer Diabetes Care, B. Braun, LifeScan, ACON Laboratories, Jiangsu Yuyue, HMD BioMedical Inc., TaiDoc, Betachek National Diagnostics, Roche Diagnostics, i-SENS, Universal Biosensors, Abbott, SANNUO, AgaMatrix Inc, and others.

Brows More Healthcare Related Research Reports:
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:
Akash Anand
Market Research Future
+1 646 845 9312

Friday 13 September 2019

Ticagrelor Market Profile | Demand, Cost and Profit | Forecast To 2027

Ticagrelor Market Overview by Share, Size, SWOT Analysis, Segmentation, Emerging Trends, Future Outlook, Applications, Insights, Profile, key Players, Future Outlook, PESTEL analysis with Regional Insights of North America, Asia-Pacific, Europe, and the Middle East & Africa, Forecast To 2027

Ticagrelor is an antiplatelet drug which is a member of a section of pharmaceuticals which tackle the problem of platelet aggression. The global Ticagrelor Market is expected to grow at a healthy growth rate during the forecast period 2017-2027. The major factors influencing the growth of the market include high patient pool suffering from heart problems, increasing development in the product by the companies, commercialization and improving market access scenarios and funding for research and development by the market players and many others. Moreover, there is a huge opportunity in developing countries that is grabbed by various market players for expanding their presence in the region. The Ticagrelor market is forecasted to demonstrate a double-digit growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period 2017 – 2027.

Global Ticagrelor Market Competitive Analysis

AstraZeneca, Eli Lilly, Boehringer, Ingelheim, Pfizer, Amgen, Merck, Roche, GSK, Alexion, Boehringer, Ingelheim Pfizer, Amgen are some of the prominent players at the forefront of competition in the Global Ticagrelor Market and are profiled in MRFR Analysis. 

Characterized by the presence of several well-established and small players, the global Ticagrelor market of appears to be highly competitive and fragmented. With well-established Ticagrelor market in the North America region major companies like AstraZeneca Eli Lilly, Pfizer, GSK, Pfizer, Amgen and various others have their home in the region and generate maximum ticagrelor market share. These companies have expanded their operating unit in various other emerging regions as well. Moreover, the other small and medium scale players are generating revenue from local market.


There has been increasing development in the product and commercialization of the product.  AstraZeneca’s a Swedish multinational pharma and biotech involved in the production since the beginning. Brilinta the company’s product in 2016 generated a sales of about $ 839 million. The product perceived 45% year on year (YoY) revenue growth in the United States and about 15% year on year increase in sales in the European market. The increase in the product revenue is majorly due to changes in the brand name of the competitor product as well as growing use of Brilinta by patients discharged from hospitals in European region. More over the development in Brilinta with the launch of 60-mg version of Brilinta, which in 2016 accounted for 10% of the total prescriptions of the drug in the United States. This development and improving market access for the product is expected to increase the growth of the revenue in 2017 as well. It is expected that the product Brilinta by AstraZeneca to exceed the $ 1.0 billion sales in 2017 and turn out to be a blockbuster therapy.

AstraZeneca furthermore concentrating on commercialization of the product in order to increase product availability across the globe. AstraZeneca announced the collaboration of Sun Pharmaceutical Industries Ltd., according to the agreement the company Sun Phrma agreed to distribute AstraZeneca’s new brand of ticagrelor “Axcer” in India. Sun Pharma is and India's top pharmaceutical company and the world's 5th largest specialty generic pharmaceutical company. This collaboration will authorize AstraZeneca to enhance usage of this molecule through wide reach to doctors and thereby helping a greater number of ACS patients.

Global Ticagrelor Market Regional Analysis

The global ticagrelor market is segmented into the various regions including Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas accounts for the largest ticagrelor market share of about more than ~40% of the market share due to extensive use product by the patients discharged from hospitals in the regions, major manufacturers developing the product in the region.


Europe is the second largest ticagrelor market followed by Asia Pacific. However, Asia Pacific market is expected to grow at the fastest growth rate due to awareness of ticagrelor, Asia Pacific accounting for more than 60% of the global population and increasing cardiovascular patients. Particularly, India and China are anticipated to be a growing and the fastest growing market. Many major players seeking opportunity and expand their presence in this region influencing the growth of the ticagrelor market.   

The Middle East & Africa holds the least share in the ticagrelor market due to lack of awareness, less market access scenarios activities, and poor medical facilities.

Wednesday 11 September 2019

Cosmetic Surgery Market Profile | Dynamics and Key Players| Forecast To 2023

Cosmetic Surgery Market Overview by Share, Size, SWOT Analysis, Segmentation, Emerging Trends, Future Outlook, Applications, Insights, Profile, key Players, Future Outlook, PESTEL analysis with Regional Insights of North America, Asia-Pacific, Europe, and the Middle East & Africa, Forecast To 2023

The Cosmetic Surgery Market is thriving on various social and cultural factors. Cosmetic surgery is a medicinal discipline where the focus is on improving the look via surgical and medical technique. It can be performed on any part of the body. The aesthetic appeal it adds is helping the market gain attention from diverse sectors. The global cosmetic surgery market can expect a lead by 7.8% CAGR during the forecast period (2017-2023) and reach a valuation worth USD 21.97 billion by the end of 2023. Market Research Future (MRFR) revealed this information in a recently published article and focused mainly on impacts that the drivers can have on the market in the coming years, along with detailed segmental analysis and the latest updates of the competitor portfolio. This approach is to provide a holistic report that can help in the understanding the cosmetic surgery market in the coming years.
The cosmetic surgery market can expect to get driven by the impacts of media, fashion, and other cultural scenarios. Recent trends and publicity are forcing may adopt these aesthetical tweaks that can uplift the appearance of a person. It is getting further thrust from the emerging medical tourism hubs like Miami and Bangkok, where the infrastructure for such treatments are widely available and at times, in a cost-effective package. High disposable income is backing the sudden demand for such surgeries. Social media and photography are also promoting the cosmetic surgery market substantially. These two fields are leading people into assessing themselves, and there, appearance becomes of chief importance which triggers the growth in the patient pool for such surgeries.


Segmentation:
MRFR segments the global cosmetic surgery market surgical procedures and non-surgical procedures.
Based on the surgical procedures, the cosmetic surgery market can be segmented into lipoplasty, cosmetic ear surgery, gynecomastia treatment, cosmetic eyelid surgery, abdominoplasty, breast augmentation, breast reduction, and breast lift. Breast augmentation and lipoplasty are at present, the most popular surgeries.
Based on the non-surgical procedures, the cosmetic surgery market comprises laser therapy of leg veins, laser hair removal, cosmetic injectables, sclerotherapy, and skin rejuvenation. Cosmetic injectables can retain its lead during the forecast period. The segment can further be sub-segmented into calcium hydroxyapatite, botulinum toxin type A, hyaluronic acid, poly-l-lactic acid, and collagen. Skin rejuvenation segment includes intense pulsed light laser treatment, Fraxel, chemical peel, noninvasive tightening, and dermabrasion.

Regional Analysis:
Geographically, the cosmetic surgery market spans across North America, Europe, Asia-Pacific, Middle East, and Africa.
North America has the maximum market share, and that can be attributed to the presence of the U.S. With its solid infrastructure and healthcare system, the U.S. is constantly ticking all the growth parameters to mount higher. Advanced technologies used by the region, the U.S. accounts for the largest market share for cosmetic surgery and is expected to maintain its dominance over the forecast period. Advanced technology implemented in the procedure is impacting the growth substantially. At the same time, increasing awareness and rising acceptability of the plastic surgery can be seen as major influencers.


The APAC region, with countries such as Japan, China, and India, can emerge as the fastest growing region. Eyelid surgeries and breast implementation are gaining popularity in Japan. Various developing countries are looking at medical tourism as an option to better economic condition.

Competitive Landscape:
Notable players profiled in the report of the cosmetic surgery market are Valeant Pharmaceuticals International, Cutera, Inc., Johnson & Johnson, Syneron Medical Ltd., Genesis Biosystems, Inc. Allergan, Inc., and others.
In 2018, French scientists developed a computer-aided design (CAD) technique that can be used to develop customized silicone implants to treat Poland syndrome. Poland syndrome is a disease where the pectoralis major muscle is missing from the chest or mal-formed which disfigures the chest. The technique would help in chest restoration.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +16468459312

Ultra-low Temperature Freezers Market Profile, Trends and Applications By 2027

  According to the MRFR reports, the global   ultra-low temperature freezers market   is projected to acquire a market size of approximately...